Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma.
Huang H, Zhu G, Shi R, Li Y, Zhang Z, Xu S, Chen C, Cao P, Pan Z, Zhang H, Liu M, Liu H, Chen J.
Huang H, et al. Among authors: chen j, chen c.
J Cancer. 2022 May 16;13(8):2631-2643. doi: 10.7150/jca.70725. eCollection 2022.
J Cancer. 2022.
PMID: 35711827
Free PMC article.